Channing Capital Management, LLC has filed a Form 13F-HR with the Securities and Exchange Commission, reporting its equity holdings as of September 30, 2026. The filing discloses the firm's ownership of 108 separate securities.
The report lists a total of 108 positions held by the firm. The filing includes a comprehensive list of common stocks, with companies ranging from large-cap industrial and financial names to smaller-cap entities in various sectors. Notable entries in the portfolio include Abbott Laboratories, Apple Inc., Boeing Co., and Wells Fargo & Co.
The filing provides specific details for each holding, including the name of the issuer, the CUSIP number, the total number of shares owned, and the total value of the position. For example, Channing Capital reports ownership of 15,087,981 shares of Abbott Laboratories, valued at $47,256,000. The firm also lists positions in companies such as Amazon.com Inc., Lazard Inc., and Valvoline Inc., with specific share counts and total values detailed in the accompanying information table.
The report was signed by David Lemanski, Head of Operations, on behalf of the firm, with the filing date listed as November 2, 2026.
